About
Ophtascan by OncoTech – the vanguard of cancer and diabetes early detection. Our AI-powered system is the first of its kind, clinically tested and validated to provide on-demand screening with precision and ease. In the fight against cancer, early detection is pivotal. It's not just about creating advanced technology; it's about delivering hope and saving lives. Ophtascan represents a leap forward in medical innovation, making comprehensive screening more accessible and efficient than ever before. Our commitment goes beyond innovation. In a world where cancer remains a leading cause of death, we strive to bridge the gap in healthcare disparities. Ophtascan is designed to be a cost-effective solution, bringing life-saving diagnostics to communities worldwide, no matter their socioeconomic status. With Ophtascan, we're not just imagining a world where cancer is conquered—we're actively expanding across the world. Stay updated on our progress, learn about our technology, and join us on this transformative journey towards a cancer free future. For more information, visit Ophtascan.ai. #Ophtascan #CancerEarlyDetection #AIRevolution #OncoTech #InnovateForLife #CancerFreeWorld
Technologies
Keywords
Company Information
-
Employees 0
Location
1 Charterhouse Mews, England, United Kingdom, EC1M